Swiss shares TFN at a glance outlook |
|
|
|
Published
:
Wed, 18 Apr 2007 07:48 |
ZURICH (Thomson Financial) - Share prices are expected to open higher led by heavyweights Roche, following consensus-beating first-quarter sales, and Nestle, boosted by strong L'Oreal sales yesterday, dealers said.In pre-bourse trading, the Swiss Market Index was 20.42 points higher at 9,248.42.Yesterday, the Swiss Market Index closed 41.90 points lower at 9,228.00, and the Swiss Performance Index was down 28.37 points at 7,407.32.FORTHCOMING EVENTSTODAY-noneTOMORROW-Converium Q1 result-Logitech FY results 2006/7-Actelion Q1 results-Lonza Q1 business update-Synthes Q1 results-Baselworld luxury goods fair through to April 19TODAY'S PRESS-Roche plans no major acquisitions, spin-offs possible - head of pharma (Handelszeitung)COMPANY NEWS-Roche's Avastin approved in Japan for advanced/recurrent colorectal cancer-Roche plans no major acquisitions, spin-offs possible - head of pharma-Roche Q1 sales reach top end of expectations, confirms sales growth target-ROCHE SAYS FY EPS TO GROW FASTER THAN SALES-Roche still sees double-digit FY sales growth at group level, pharma div-Roche Q1 diagnostics sales 2.216 bln sfr, up 6 pct year on year-Roche Q1 pharma sales 9.142 bln sfr, up 18 pct year on year-Roche Q1 sales 11.4 bln sfr, up 16 pct year on year-Credit Suisse to acquire US mortgage lender Lime Financial for undisclosed sum-Kuoni bookings as of April 15 up 13 pct year on year-Bodycote rejects Sulzer's revised 332p/shr offer; says it still undervalues company-Biomarin to create 100 mln sfr of approved share capital for acquisitions, license buysMACROECONOMIC NEWS-noneMARKET NEWS/SENTIMENTjohanna.treeck@thomson.comjmt/jlcCOPYRIGHTCopyright AFX News Limited 2007. All rights reserved.The copying, republication or redistribution of AFX News Content, including by framing or similar means, is expressly prohibited without the prior written consent of AFX News.
|
|
|
|
|
|